[Remote development of transient ischemic attack, reversible ischemic neurologic deficit and infarct with minimum residual damage. Prospective study of 149 patients treated medically].
Calandre
L
L
Gomara
S
S
Ozaita
G
G
Bermejo
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D002544:Cerebral Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D011446:Prospective Studies
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin
Evolución a largo plazo de los ataques isquémicos transitorios, déficit neurológicos isquémicos reversibles e infartos con residuo mínimo. Estudio prospectivo de 149 pacientes tratados médicamente.